Investment Strategy Brief — May 22, 2026
As of May 22, 2026, we are tracking key developments affecting our portfolio, including Krafton’s breakout success, profit-taking in shipbuilding stocks, and the delisting of Kumyang. Here is the latest curated research.
Investment Strategy Summary — 2026-05-22
Large-cap & Key Holding Reports
Mirae Asset Securities (006800)
Despite becoming a top-tier securities stock following a recent rally, analyst opinions on Mirae Asset Securities are sharply divided. There are currently 6 "Buy" vs. 10 "Hold" ratings, with a neutral stance prevailing. While the company is braced for its "highest-ever quarterly performance" due to a stock market boom and expectations surrounding investments in SpaceX, valuation concerns following the share price surge are fueling the cautious outlook.
According to ThinkPool, Mirae Asset Securities is signaling record results, and the fact that its market cap briefly surpassed Shinhan Financial Group is viewed by the market as a positive sign of revaluation.
Shipbuilding Stocks (Hanwha Ocean, HD Korea Shipbuilding & Offshore Engineering, Samsung Heavy Industries)
On May 19, domestic shipbuilding stocks experienced mixed trading as profit-taking pressure intensified throughout the day. Recent surges have triggered profit-taking and foreign capital outflows, leading to increased volatility, particularly among the major shipbuilders.
While brokerage consensus and real-time stock data for Hanwha Ocean can be accessed via Korea Economic Daily Market and AlphaSquare, specific target price updates since 2026-05-20 are currently unavailable.
Kumyang — Delisting Decision (Caution Advised)
On May 20, 2026, the Korea Exchange held a KOSPI Listing Public Disclosure Committee meeting and decided to delist Kumyang. The exchange is expected to announce the delisting by the 26th. Once dubbed a leader in the secondary battery sector, Kumyang’s forced exit serves as a warning sign for investors in that industry.
Kyunghyang Shinmun also confirmed and reported the Exchange’s decision to delist Kumyang on the same date.
Bio & Tech Growth Stock Analysis
NCSoft
A sudden shift was detected in NCSoft’s financial structure in Q1 2026. The company liquidated a significant portion of its diversified investments, such as bonds and financial products, boosting its cash and cash equivalents to over 1 trillion KRW. This is being watched closely as it could signal preparations for an M&A or a major new investment.
Krafton (259960)
Krafton’s new title, "Subnautica 2," has surpassed 4 million units in cumulative sales just 5 days after its Early Access launch, continuing its strong momentum.
This follows a record-breaking first quarter with 1.3714 trillion KRW in revenue and 561.6 billion KRW in operating profit. Furthermore, Krafton ranked first in operating profit among major domestic game companies in Q1, widening the gap between large and mid-sized developers.
Industry & Energy Sector Strategy
Hanwha Ocean (042660)
As of May 19, 2026, Hanwha Ocean is facing short-term adjustment pressure due to profit-taking and foreign liquidity concerns following its recent rally. While the overall shipbuilding industry remains healthy, investors should be mindful of short-term volatility. Updated target price data is currently unavailable.
SungEel HiTech / DL E&C / Yunseong F&C
No specific brokerage reports or updated investment ratings for these stocks have been identified since May 20, 2026. Data pending.
Overall Investment Direction
Current market variables are summarized below:
- Krafton: With record quarterly results and a successful new game launch, it likely remains the top pick in the gaming sector.
- Mirae Asset Securities: Earnings momentum is clear, but many analysts remain neutral. Exercise caution regarding short-term chase-buying.
- Shipbuilding Stocks: Short-term profit-taking pressure exists. While the industry outlook is sound, monitoring foreign capital flow is essential.
- Kumyang: Delisting confirmed. Shareholders need to respond immediately.
- NCSoft: A massive increase in cash assets suggests structural changes ahead. Future share price direction depends on how this capital is deployed.
New brokerage report data for other portfolio holdings—including Genexine, Seegene, L&C Bio, EOFlow, Cellid, and SungEel HiTech—since 2026-05-20 is pending acquisition.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
